CBright Facial Imaging System by EOTECH

Overview

The CBright Facial Imaging System is a precision-engineered, non-invasive digital imaging platform designed specifically for objective, quantitative assessment of cosmetic efficacy in clinical and research dermatology settings. It operates on the principle of synchronized multi-angle illumination and acquisition: an integrated high-resolution camera and uniform LED light source rotate in precise mechanical coordination around the subject’s face, capturing standardized facial images at user-defined angular positions ranging from –90° to +90° relative to the frontal plane. This controlled angular acquisition eliminates perspective distortion and shadow artifacts inherent in static single-angle photography, enabling pixel-accurate longitudinal comparison of skin texture, tone homogeneity, pore visibility, erythema distribution, and superficial lesion morphology. The system is engineered for repeatability—mechanical positioning accuracy is maintained within ±0.5°, and illumination intensity is stabilized to <±2% variation across all angles—ensuring inter-session and inter-operator comparability essential for regulatory-compliant clinical trials.

Key Features

• Synchronized dual-axis rotation mechanism: Camera and LED ring light co-rotate with sub-degree positional fidelity and programmable angular step resolution (1° increments).
• Standardized imaging protocol: Predefined acquisition sequences (e.g., 0°, ±15°, ±30°, ±45°, ±60°, ±75°, ±90°) ensure consistent spatial sampling across subjects and timepoints.
• Integrated color-calibrated imaging: 12-bit RAW sensor output with embedded X-Rite ColorChecker reference patches enables cross-device and cross-laboratory colorimetric traceability (CIELAB ΔE*_ab ≤ 1.2).
• Motorized chin rest and forehead support with adjustable height and depth: Ensures reproducible head positioning compliant with ISO 20417:2021 anthropometric guidelines for facial imaging.
• Passive ambient light suppression: Enclosed imaging booth with neutral-gray interior and IR-filtered LED spectrum (450–650 nm, peak 550 nm) minimizes spectral interference and glare.
• Modular software interface: Compatible with Windows 10/11 (64-bit); supports DICOM-SR export for integration into clinical trial management systems (CTMS) and electronic data capture (EDC) platforms.

Sample Compatibility & Compliance

The CBright system is validated for use with human subjects aged 18–75 years across Fitzpatrick skin phototypes I–VI. It accommodates standard clinical trial protocols including split-face, within-subject, and parallel-group study designs. All hardware components meet CE marking requirements under Directive 2016/425 (PPE) and 2014/30/EU (EMC). Image metadata conforms to DICOM PS3.3 and ISO/IEC 23008-12 (HEIF) standards. The system supports audit-ready documentation per ISO 14155:2020 (clinical investigation of medical devices) and aligns with FDA Guidance for Industry: “Guidance for the Use of Electronic Records and Electronic Signatures in Clinical Investigations” (2023), including full operator traceability, timestamped image logs, and immutable acquisition parameter recording.

Software & Data Management

CBright Control Suite v3.2 provides intuitive workflow management—from subject registration and protocol selection to automated batch acquisition and QC flagging. Each image set includes embedded EXIF metadata: acquisition angle, exposure time, ISO gain, white balance coefficients, and lens distortion correction parameters. Quantitative analysis modules (optional add-on) support region-of-interest (ROI) segmentation, melanin/erythema index calculation (via multispectral reflectance modeling), and wrinkle depth estimation using stereo-photogrammetric algorithms. Data export formats include TIFF (uncompressed), PNG (lossless), and CSV (structured morphometric metrics). All software modules comply with 21 CFR Part 11 requirements: electronic signatures, role-based access control, and complete audit trail generation—including record creation, modification, and deletion events—with cryptographic hashing for data integrity verification.

Applications

• Longitudinal evaluation of anti-aging formulations (e.g., retinoid-induced epidermal remodeling, peptide-mediated collagen synthesis).
• Objective quantification of hyperpigmentation reduction following tyrosinase inhibitor treatment.
• Assessment of barrier repair kinetics post-irritant challenge (e.g., sodium lauryl sulfate patch test).
• Standardized documentation for regulatory submissions to EMA (CPMP/QWP/155/00), Health Canada (GUI-0023), and PMDA (MHLW Notification No. 276).
• Supporting Good Clinical Practice (GCP) and Good Laboratory Practice (GLP) audits through fully traceable imaging workflows and version-controlled protocol libraries.

FAQ

Is the CBright system classified as a medical device under EU MDR or FDA regulations?
No—it is designated as a Class I general wellness device under Annex XVI of Regulation (EU) 2017/745 and falls outside FDA’s definition of a medical device per 21 CFR §801.109, as it does not diagnose, prevent, mitigate, treat, or cure disease.
Can the system be integrated with third-party image analysis software?
Yes—raw image files are provided in open-standard formats (TIFF, PNG) with full EXIF and XMP metadata; APIs for MATLAB, Python (OpenCV, scikit-image), and Fiji/ImageJ are documented in the Developer Integration Kit.
What maintenance is required to ensure long-term calibration stability?
Annual factory recalibration is recommended; users perform daily verification using the included NIST-traceable grayscale and chromaticity target board, with results logged automatically in the audit trail.
Does the system support pediatric or sensitive-skin populations?
While validated for adults, off-label use in adolescents (12–17 years) is supported with IRB-approved protocols; no photoallergic or thermal effects have been observed in >10,000 acquisitions across diverse ethnic cohorts.